Free Trial

Public Employees Retirement System of Ohio Trims Position in Danaher Corporation $DHR

Danaher logo with Medical background

Key Points

  • The Public Employees Retirement System of Ohio has reduced its holdings in Danaher Corporation by 2.2%, now owning 261,487 shares valued at approximately $51.65 million.
  • Danaher recently reported earnings per share of $1.80, exceeding analysts' estimates, alongside a quarterly revenue of $5.94 billion, up 3.4% year-over-year.
  • The company announced a quarterly dividend of $0.32 per share, with a yield of 0.7%, set to be paid on October 31st.
  • Interested in Danaher? Here are five stocks we like better.

Public Employees Retirement System of Ohio lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 2.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 261,487 shares of the conglomerate's stock after selling 5,831 shares during the quarter. Public Employees Retirement System of Ohio's holdings in Danaher were worth $51,654,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in DHR. Bank Pictet & Cie Europe AG lifted its stake in shares of Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after purchasing an additional 35,730 shares during the period. Voloridge Investment Management LLC purchased a new position in shares of Danaher during the 4th quarter worth $3,763,000. Ameriflex Group Inc. purchased a new position in shares of Danaher during the 4th quarter worth $38,000. Heck Capital Advisors LLC purchased a new position in shares of Danaher during the 4th quarter worth $27,000. Finally, Park Square Financial Group LLC purchased a new position in shares of Danaher during the 4th quarter worth $49,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on DHR shares. Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Evercore ISI cut their target price on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Robert W. Baird increased their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Deutsche Bank Aktiengesellschaft cut their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $245.91.

Read Our Latest Research Report on DHR

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.20% of the company's stock.

Danaher Stock Down 0.6%

Shares of NYSE DHR opened at $189.24 on Wednesday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The firm has a market cap of $135.50 billion, a price-to-earnings ratio of 40.26, a PEG ratio of 2.66 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The stock's 50-day simple moving average is $199.95 and its 200-day simple moving average is $197.97.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the company earned $1.72 earnings per share. The company's revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio (DPR) is 27.23%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.